We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
FIGS
FIGS
$2.21B
| $8.6K | ﹤0.01% |
+1,040
| New | +$7.91K |
|
1852
BlackLine
BL
$1.69B
| $8.23K | ﹤0.01% |
153
-398,949
| -100% | -$22.1M |
|
1853
First Hawaiian
FHB
$3.15B
| $8.2K | ﹤0.01% |
+455
| New | +$8.35K |
|
1854
BOK Financial
BOKF
$8.25B
| $8.16K | ﹤0.01% |
+101
| New | +$8.32K |
|
|
TRML
1855
DELISTED
Tourmaline Bio
TRML
| $8.16K | ﹤0.01% |
268
+7
| +3% | +$179 |
|
1856
Asbury Automotive
ABG
$3.68B
| $7.93K | ﹤0.01% |
33
-18
| -35% | -$3.79K |
|
1857
Benchmark Electronics
BHE
$2.61B
| $7.85K | ﹤0.01% |
304
| – | – |
|
|
PBPB
1858
DELISTED
Potbelly
PBPB
| $7.74K | ﹤0.01% |
882
-1,296
| -60% | -$11.4K |
|
|
DMC
1859
Del Monte Corp
DMC
$1.48B
| $7.61K | ﹤0.01% |
296
-154
| -34% | -$4.25K |
|
1860
Meridian
MRBK
$236M
| $7.49K | ﹤0.01% |
764
| – | – |
|
1861
Ferrari
RACE
$71.5B
| $7.48K | ﹤0.01% |
+23
| New | +$6.7K |
|
|
BBUC
1862
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.26B
| $7.46K | ﹤0.01% |
395
-346
| -47% | -$6.94K |
|
|
ADTH
1863
DELISTED
AdTheorent Holding Co
ADTH
| $7.45K | ﹤0.01% |
+5,320
| New | +$8.09K |
|
1864
Federal Agricultural Mortgage
AGM
$2.44B
| $7.33K | ﹤0.01% |
+51
| New | +$6.99K |
|
|
PAMT
1865
PAMT Corp
PAMT
$270M
| $7.15K | ﹤0.01% |
267
-234
| -47% | -$5.98K |
|
1866
Agilysys
AGYS
$2.95B
| $7.14K | ﹤0.01% |
104
+85
| +447% | +$6.4K |
|
1867
Viemed Healthcare
VMD
$333M
| $7.07K | ﹤0.01% |
723
+601
| +493% | +$6.1K |
|
|
TPH
1868
DELISTED
Tri Pointe Homes
TPH
| $7.07K | ﹤0.01% |
215
-109
| -34% | -$3.19K |
|
1869
Target Hospitality
TH
$1.84B
| $6.96K | ﹤0.01% |
519
-401,321
| -100% | -$5.55M |
|
1870
Greenlight Captial
GLRE
$493M
| $6.89K | ﹤0.01% |
654
+569
| +669% | +$5.63K |
|
1871
Liberty Latin America Class C
LILAK
$1.73B
| $6.84K | ﹤0.01% |
+873
| New | +$6.51K |
|
1872
Ralph Lauren
RL
$20B
| $6.78K | ﹤0.01% |
+55
| New | +$6.35K |
|
1873
LSI Industries
LYTS
$748M
| $6.72K | ﹤0.01% |
535
| – | – |
|
|
XRN
1874
Chiron Real Estate Inc
XRN
$478M
| $6.57K | ﹤0.01% |
144
-126
| -47% | -$5.69K |
|
|
PLYM
1875
DELISTED
Plymouth Industrial REIT
PLYM
| $6.47K | ﹤0.01% |
+281
| New | +$6.01K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.